Economic impact of the Elecsys anti-Müllerian hormone Plus immunoassay for anti-Müllerian hormone testing as part of polycystic ovary syndrome assessment in the United Kingdom.

Economic impact of the Elecsys anti-Müllerian hormone Plus immunoassay for anti-Müllerian hormone testing as part of polycystic ovary syndrome assessment in the United Kingdom.

Show other versions (1)

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women. Current international PCOS assessment and management guidelines recommend anti-Müllerian hormone (AMH) as an alternative to transvaginal ultrasound for assessing polycystic ovarian morphology, which is one of three c...

Full description

Saved in:
Bibliographic Details
Main Authors: Osvaldo Ulises Garay, Anna-Maria Olziersky, Joop Laven, Rebecca Mawson, Terhi Piltonen, Stephen Franks, Johanna Sillman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0326162
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items